Cardlytics Statistics
Total Valuation
Cardlytics has a market cap or net worth of $39.19 million. The enterprise value is $205.34 million.
Important Dates
The last earnings date was Wednesday, March 4, 2026, after market close.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cardlytics has 55.05 million shares outstanding. The number of shares has increased by 9.83% in one year.
| Current Share Class | 55.05M |
| Shares Outstanding | 55.05M |
| Shares Change (YoY) | +9.83% |
| Shares Change (QoQ) | +1.54% |
| Owned by Insiders (%) | 3.30% |
| Owned by Institutions (%) | 30.32% |
| Float | 48.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.17 |
| Forward PS | 0.17 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.40 |
| P/OCF Ratio | 4.17 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 23.31 |
Financial Position
The company has a current ratio of 1.75
| Current Ratio | 1.75 |
| Quick Ratio | 1.71 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 24.44 |
| Interest Coverage | -4.43 |
Financial Efficiency
Return on equity (ROE) is -326.02% and return on invested capital (ROIC) is -11.77%.
| Return on Equity (ROE) | -326.02% |
| Return on Assets (ROA) | -8.69% |
| Return on Invested Capital (ROIC) | -11.77% |
| Return on Capital Employed (ROCE) | -22.75% |
| Weighted Average Cost of Capital (WACC) | 4.87% |
| Revenue Per Employee | $635,621 |
| Profits Per Employee | -$281,984 |
| Employee Count | 367 |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.16% in the last 52 weeks. The beta is 1.09, so Cardlytics's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -61.16% |
| 50-Day Moving Average | 1.02 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 31.59 |
| Average Volume (20 Days) | 779,082 |
Short Selling Information
The latest short interest is 6.95 million, so 12.63% of the outstanding shares have been sold short.
| Short Interest | 6.95M |
| Short Previous Month | 6.45M |
| Short % of Shares Out | 12.63% |
| Short % of Float | 14.47% |
| Short Ratio (days to cover) | 9.74 |
Income Statement
In the last 12 months, Cardlytics had revenue of $233.27 million and -$103.49 million in losses. Loss per share was -$1.95.
| Revenue | 233.27M |
| Gross Profit | 104.61M |
| Operating Income | -47.14M |
| Pretax Income | -103.49M |
| Net Income | -103.49M |
| EBITDA | -21.90M |
| EBIT | -47.14M |
| Loss Per Share | -$1.95 |
Full Income StatementBalance Sheet
The company has $48.72 million in cash and $215.31 million in debt, with a net cash position of -$166.60 million or -$3.03 per share.
| Cash & Cash Equivalents | 48.72M |
| Total Debt | 215.31M |
| Net Cash | -166.60M |
| Net Cash Per Share | -$3.03 |
| Equity (Book Value) | -6.51M |
| Book Value Per Share | -0.12 |
| Working Capital | 58.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $9.29 million and capital expenditures -$480,000, giving a free cash flow of $8.81 million.
| Operating Cash Flow | 9.29M |
| Capital Expenditures | -480,000 |
| Free Cash Flow | 8.81M |
| FCF Per Share | $0.16 |
Full Cash Flow StatementMargins
Gross margin is 44.85%, with operating and profit margins of -20.21% and -44.36%.
| Gross Margin | 44.85% |
| Operating Margin | -20.21% |
| Pretax Margin | -44.36% |
| Profit Margin | -44.36% |
| EBITDA Margin | -9.39% |
| EBIT Margin | -20.21% |
| FCF Margin | 3.78% |
Dividends & Yields
Cardlytics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.83% |
| Shareholder Yield | -9.83% |
| Earnings Yield | -267.09% |
| FCF Yield | 22.74% |
Analyst Forecast
The average price target for Cardlytics is $2.25, which is 216.10% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.25 |
| Price Target Difference | 216.10% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cardlytics has an Altman Z-Score of -6.15 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.15 |
| Piotroski F-Score | 5 |
